Diabetes Clinical Trials in San Antonio

Showing 181-200 of 559 trials

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

NCT01619332

This study is a three part study to assess the safety and efficacy of LEZ763 on normal healthy volunteers and patients with Type 2 Diabetes.

Type II Diabetes

Novartis Pharmaceuticals220 participantsStarted Mar 2012

Chula Vista, California, United States • Miami, Florida, United States • Orlando, Florida, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

NCT00658021

The primary objective of this study is to test the hypothesis that glycemic control, as measured by change in hemoglobin A1c (HbA1c) from baseline to endpoint, with exenatide is superior to that of placebo after 28 weeks of treatment in adolescent patients with type 2 diabetes who are naïve to antidiabetes agents, or patients who are being treated with metformin, an SU, or a combination of metformin and an SU

Type 2 Diabetes

AstraZeneca122 participantsStarted May 2008

Birmingham, Alabama, United States • Tucson, Arizona, United States • Los Angeles, California, United States +50 more locations

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Diabetes Trials in Other Cities

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Rituximab in New Onset Type 1 Diabetes

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

Patient and Provider Assessment of Lipid Management Registry

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Other Conditions in San Antonio